Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026)
Liquidia (LQDA) posted quarterly Depreciation & Amortization (CF) of $497000.0 for Q1 2026, up 10.2% year-over-year from $451000.0 in Q1 2025, and up 55.31% quarter-over-quarter from $320000.0 in Q4 2025.
Liquidia (LQDA) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Liquidia's Depreciation & Amortization (CF) history runs 7 years deep, the most recent figure standing at $497000.0 for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 10.2% year-over-year to $497000.0; the TTM figure through Mar 2026 stood at $1.6 million (down 27.1% YoY), while the FY2025 annual figure was $1.5 million, down 30.45% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $497000.0, up from $320000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $1.1 million in Q3 2022, with the low at $281000.0 in Q2 2025.
- The 5-year median for Depreciation & Amortization (CF) is $518000.0 (2024), against an average of $591000.0.
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) slumped 54.43% in 2023, then rose 18.68% in 2024.
- Liquidia's Depreciation & Amortization (CF) stood at $566000.0 in 2022, then declined by 10.6% to $506000.0 in 2023, then climbed by 2.37% to $518000.0 in 2024, then slumped by 38.22% to $320000.0 in 2025, then soared by 55.31% to $497000.0 in 2026.
- Business Quant data shows LQDA's Depreciation & Amortization (CF) at $497000.0 in Q1 2026, $320000.0 in Q4 2025, and $476000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 241.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 1.02 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 24.20 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 672.30 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 171.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Liquidia | 6.40 Bn | 6.12 Bn | 160.92 Mn | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,000.00 |
| Jun 30, 2026 | 400,000.00 |
| Mar 31, 2026 | 497,000.00 |
| Mar 31, 2026 | 497,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Sep 30, 2025 | 476,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Jun 30, 2025 | 281,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Mar 31, 2025 | 451,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Dec 31, 2024 | 518,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 580,000.00 |
| Jun 30, 2024 | 580,000.00 |
| Mar 31, 2024 | 489,000.00 |
| Mar 31, 2024 | 489,000.00 |